Ludwiniak, K.; Olejnik, P.; Maciejewska, O.; Opuchlik, A.; Małyszko, J.; Golenia, A.
Admission eGFR as a Marker of Systemic Vulnerability in Patients with Spontaneous Intracerebral Hemorrhage: Impact of Premorbid Disability and Acute Kidney Injury on Outcomes. J. Clin. Med. 2026, 15, 562.
https://doi.org/10.3390/jcm15020562
AMA Style
Ludwiniak K, Olejnik P, Maciejewska O, Opuchlik A, Małyszko J, Golenia A.
Admission eGFR as a Marker of Systemic Vulnerability in Patients with Spontaneous Intracerebral Hemorrhage: Impact of Premorbid Disability and Acute Kidney Injury on Outcomes. Journal of Clinical Medicine. 2026; 15(2):562.
https://doi.org/10.3390/jcm15020562
Chicago/Turabian Style
Ludwiniak, Kamil, Piotr Olejnik, Oliwia Maciejewska, Andrzej Opuchlik, Jolanta Małyszko, and Aleksandra Golenia.
2026. "Admission eGFR as a Marker of Systemic Vulnerability in Patients with Spontaneous Intracerebral Hemorrhage: Impact of Premorbid Disability and Acute Kidney Injury on Outcomes" Journal of Clinical Medicine 15, no. 2: 562.
https://doi.org/10.3390/jcm15020562
APA Style
Ludwiniak, K., Olejnik, P., Maciejewska, O., Opuchlik, A., Małyszko, J., & Golenia, A.
(2026). Admission eGFR as a Marker of Systemic Vulnerability in Patients with Spontaneous Intracerebral Hemorrhage: Impact of Premorbid Disability and Acute Kidney Injury on Outcomes. Journal of Clinical Medicine, 15(2), 562.
https://doi.org/10.3390/jcm15020562
